Structure (Tiopronin Delayed Release Tablets 300 mg 1)
Tiopronin Tablet, Delayed Release
Product Images NDC 60219-2009
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tiopronin (NDC 60219-2009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Tiopronin Delayed Release Tablets 300 mg 2)
This is a description of Tiopronin tablets. Each delayed-release tablet contains 300 mg of Tiopronin. The usual dosage should be determined by referring to the prescribing information. The tablets come in a package that is child-resistant. They should be stored at a temperature between 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F), according to USP Controlled Room Temperature guidelines. It is important to keep this medication, and all medications, out of the reach of children. The tablets are manufactured by Amneal Pharmaceuticals Pvt. Ltd, located in Ahmedabad, India, and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
